A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.

MLA

Karges, Johannes, et al. “A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.” Angewandte Chemie, vol. 132, no. 18, Apr. 2020, pp. 7135–41. EBSCOhost, https://doi.org/10.1002/ange.201916400.

APA

Karges, J., Yempala, T., Tharaud, M., Gibson, D., & Gasser, G. (2020). A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers. Angewandte Chemie, 132(18), 7135–7141. https://doi.org/10.1002/ange.201916400

Chicago

Karges, Johannes, Thirumal Yempala, Mickaël Tharaud, Dan Gibson, and Gilles Gasser. 2020. “A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.” Angewandte Chemie 132 (18): 7135–41. doi:10.1002/ange.201916400.